Scilex Holding (SCLX) Operating Income (QoQ) (2020 - 2026)

Scilex Holding (SCLX) Operating Income (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Scilex Holding 58.57 Mn -91.35 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 71.04%
Dec 31, 2025 40.44%
Sep 30, 2025 -809.50%
Jun 30, 2025 26.49%
Mar 31, 2025 1.69%
Dec 31, 2024 -42.48%
Sep 30, 2024 -27.49%
Jun 30, 2024 19.79%
Mar 31, 2024 -6.21%
Dec 31, 2023 52.74%
Sep 30, 2023 -70.09%
Jun 30, 2023 10.44%
Mar 31, 2023 -29.04%
Dec 31, 2022 -85.96%
Sep 30, 2022 7.45%
Jun 30, 2022 -30.26%
Mar 31, 2022 75.00%
Dec 31, 2021 -12,329.10%
Sep 30, 2021 -64.60%
Jun 30, 2021 -4.23%